UBS reiterates CoreWeave stock rating citing strong Q3 results
UBS reiterated a Buy rating on CoreWeave (CRWV) with a $105 price target, citing strong Q3 2026 results. Revenue grew 168% to $3.7B, exceeding guidance. The stock, trading at $58.03, is undervalued according to UBS. CoreWeave raised its 2027 guidance and reported sold-out capacity. Shares rose 8% post-earnings. Other firms adjusted price targets, citing capital strategy and funding concerns.
How this was made
The 30-second read
Why it matters
The fresh earnings beat and upgraded guidance provide a clear catalyst for price appreciation, outweighing prior concerns about capital structure.
Market read
The earnings surprise and higher guidance are likely to drive short‑term buying interest in CRWV and may lift sentiment across the AI‑cloud niche.
What to watch
The company's avoidance of unsecured debt could limit flexibility if growth slows; funding strategy remains a risk.
Background
CoreWeave is a fast‑growing AI cloud provider that has been scaling capacity to meet demand. Recent analyst coverage has been mixed, with several firms lowering targets amid funding concerns.
Ticker impact
UBS reiterated a Buy rating on CoreWeave with a $105 price target after the company reported Q3 2026 revenue of $3.7 B, up 168% YoY, and raised full‑year 2027 guidance.
likely upward pressure as the market prices in the higher guidance and new $105 target.
The earnings beat and raised guidance are fresh, material information for a mid‑cap AI cloud provider, prompting analysts to lift targets.
Market effects
Strengthens the AI‑cloud services sector outlook, supporting peers with similar exposure.
U.S. tech equities may see modest gains as the earnings beat reinforces growth narratives.
Limited to AI‑related stocks; no broad macro impact.
Counterpoint
Some investors may view the rapid capacity sell‑out as a sign of overextension and potential future margin pressure.
Key entities
- CompanyCoreWeave
AI cloud infrastructure provider (NASDAQ:CRWV).
- AnalystUBS
Investment bank that reiterated a Buy rating and set a $105 price target.



